Your browser doesn't support javascript.
loading
Effectiveness and Safety of A Nutraceutical Formulation for the Treatment of Functional Dyspepsia in Primary Care.
Tursi, Antonio; Picchio, Marcello; Elisei, Walter; Allegretta, Leonardo; Benedicenti, Pierluigi; Bossa, Fabrizio; Di Bella, Simone; Elefante, Antonio; Gallina, Stefano; Greco, Federica; Maurichi, Francesco; Palieri, Antonio Pio; Penna, Antonio; Pranzo, Giuseppe; Rizzo, Giovanni Luca; Brandimarte, Giovanni; Abenavoli, Ludovico; Alfieri, Maria Santa; Antonino, Natale; Autorino, Carlo; Bellomo, Pasquale; Casamassima, Carlo; Colucci, Basilio Paolo; De Cristofaro, Vincenzo; Demauro, Rocco; Derenzio, Pietro; Detommasi, Francesco; Fazio, Michele; Ferrari, Vincenzo; Gallo, Alessio; Greco, Donatella; Lisco, Vito; Lore, Francesco; Manfredi, Michele; Marsano, Giorgio; Mascoli, Pasquale; Mazzilli, Luigi; Messa, Giovanni; Minoretti, Giulio; Misciagna, Pasquale; Monterisi, Francesco; Nappi, Saverio; Resta, Anna Rosa; Saponaro, Pasquale; Sbarra, Giovanni; Scutifero, Salvatore; Selvaggio, Vincenzo; Sica, Giuseppe; Tarallo, Mario; Torelli, Giancarlo.
Affiliation
  • Tursi A; Territorial Gastroenterology Service, ASL BAT, Andria (BT), Italy.
  • Picchio M; Division of Surgery, "P. Colombo" Hospital, ASL Roma 6, Velletri (Rome), Italy.
  • Elisei W; Division of Gastroenterology, "S. Camillo" Hospital, Rome, Italy.
  • Allegretta L; Division of Gastroenterology, "Santa Caterina Novella" Hospital, Galatina (LE), Italy.
  • Benedicenti P; Division of Internal Medicine, "Card. Panico" Hospital, Tricase (LE), Italy.
  • Bossa F; Division of Gastroenterology, IRCCS "Casa Sollievo della Sofferenza" Hospital, S. Giovanni Rotondo (FG), Italy.
  • Di Bella S; Division of Gastroenterology and Digestive Endoscopy, "A. Perrino" Hospital, Brindisi, Italy.
  • Elefante A; Territorial Gastroenterology Service, Mesagne Territorial Hospital, ASL BR, Mesagne (BR), Italy.
  • Gallina S; Division of Internal Medicine, "Card. Panico" Hospital, Tricase (LE), Italy.
  • Greco F; Department of Health Sciences, Magna Graecia University, Catanzaro, Italy.
  • Maurichi F; Division of Internal Medicine, "Card. Panico" Hospital, Tricase (LE), Italy.
  • Palieri AP; Territorial Gastroenterology Service, ASL FG, Foggia, Italy.
  • Penna A; Ambulatory of Territorial Gastroenterology, ASL BA, Bari, Italy.
  • Pranzo G; Ambulatory of Digestive Endoscopy, "Valle D'Itria" Hospital, Martina Franca (TA), Italy.
  • Rizzo GL; Division of Gastroenterology and Digestive Endoscopy, "A. Perrino" Hospital, Brindisi, Italy.
  • Brandimarte G; Division of Internal Medicine and Gastroenterology, "Cristo Re" Hospital, Rome, Italy.
  • Abenavoli L; Department of Health Sciences, Magna Graecia University, Catanzaro, Italy.
  • Alfieri MS; General Pratictioner, Cicciano, Naples, Italy.
  • Antonino N; General Pratictioner and Private Gastroenterologist, Bisceglie (Barletta-Andria-Trani), Italy.
  • Autorino C; General Pratictioner, Palese, Bari, Italy.
  • Bellomo P; General Pratictioner, Bari, Italy.
  • Casamassima C; General Pratictioner and Private Gastroenterologist, S. Ferdinando di Puglia (Barletta-Andria-Trani), Italy.
  • Colucci BP; General Pratictioner, Lucera (FG), Italy.
  • De Cristofaro V; General Pratictioner, Lapio (AV), Italy.
  • Demauro R; General Pratictioner, Grumo Appula, Bari, Italy.
  • Derenzio P; General Pratictioner, Bitetto, Bari, Italy.
  • Detommasi F; General Pratictioner, Monopoli, Bari, Italy.
  • Fazio M; General Pratictioner, Conversano, Bari, Italy.
  • Ferrari V; General Pratictioner, Parabita, Bari, Italy.
  • Gallo A; General Pratictioner, Bari, Italy.
  • Greco D; General Pratictioner, Noicattaro, Bari, Italy.
  • Lisco V; General Pratictioner, Bari, Italy.
  • Lore F; General Pratictioner, Monopoli, Bari, Italy.
  • Manfredi M; General Pratictioner, Triggiano, Bari, Italy.
  • Marsano G; General Pratictioner and Private Neurologist, Bari, Italy.
  • Mascoli P; General Pratictioner, Corato, Bari, Italy.
  • Mazzilli L; General Pratictioner, Corato, Bari, Italy.
  • Messa G; General Pratictioner, Triggiano, Bari, Italy.
  • Minoretti G; General Pratictioner, Bitonto, Bari, Italy.
  • Misciagna P; General Pratictioner, Grumo Appula, Bari, Italy.
  • Monterisi F; General Pratictioner, Trani (Barletta-Andria-Trani), Italy.
  • Nappi S; General Pratictioner, Molfetta, Bari, Italy.
  • Resta AR; General Pratictioner, Gioia del Colle, Bari, Italy.
  • Saponaro P; General Pratictioner, Bari, Italy.
  • Sbarra G; General Pratictioner, Terzigno, Naples (NA), Italy.
  • Scutifero S; General Pratictioner, Faggiano (TA), Italy.
  • Selvaggio V; General Pratictioner, Triggiano, Bari, Italy.
  • Sica G; General Pratictioner, Avellino, Italy.
  • Tarallo M; General Pratictioner and Private Endocrinologist, Bari, Italy.
  • Torelli G; General Pratictioner, Corato, Bari, Italy.
Rev Recent Clin Trials ; 16(3): 329-334, 2021.
Article in En | MEDLINE | ID: mdl-34126909
ABSTRACT

BACKGROUND:

Although FD may affect up to 10% of the general population, the therapy for FD is not standard. Recently, ginger-based food supplements have been proposed in order to restore FD symptoms. Our aim was to assess the efficacy of a new nutraceutical formulation containing extract of gingerol and thymus as a possible natural treatment in managing the symptoms of functional dyspepsia (FD).

METHODS:

We retrospectively analyzed the efficacy and safety profiles of a nutraceutical formulation containing Zingiber officinalis root extract and a standardized Thymus extract. It was administered as 1 ml/day twice a day for 90 days. Patients were assessed at baseline and after 1, 2 and 3 months of treatment, following a month of pharmacological washout by completing a questionnaire reporting the trend of the following symptoms epigastric pain, epigastric heaviness, early satiety, belching, and regurgitation. Every symptom was assessed by a Visual Analogic Scale (VAS), ranging from 0= absence to 10= maximal severity.

RESULTS:

We enrolled 272 patients (99 males and 173 females; median IQR age 49.5, 36-64 yrs). Obesity (BMI>30) was present in 28 (12.5%) patients; smokers were 83 (30.5%); and comorbidities were present in 107 (39.3%) patients. Improvement of symptom scores during treatment and one month after its suspension was extremely significant (p<0.000).

CONCLUSION:

This large study found that nutraceutical formulation could be one of the tools for an empirical approach to treat patients with FD, especially when a non-conventional drug treatment is preferable for the patient and considered suitable by the physician.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dyspepsia Type of study: Observational_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Rev Recent Clin Trials Journal subject: MEDICINA / TERAPEUTICA Year: 2021 Document type: Article Affiliation country: Italia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dyspepsia Type of study: Observational_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Rev Recent Clin Trials Journal subject: MEDICINA / TERAPEUTICA Year: 2021 Document type: Article Affiliation country: Italia
...